BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34441354)

  • 1. Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening.
    Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
    Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
    J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
    Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
    Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
    Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
    Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
    Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16INK4a as an adjunct marker in liquid-based cervical cytology.
    Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
    Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.
    Areán-Cuns C; Mercado-Gutiérrez M; Paniello-Alastruey I; Mallor-Giménez F; Córdoba-Iturriagagoitia A; Lozano-Escario M; Santamaria-Martínez M
    Virchows Arch; 2018 Nov; 473(5):599-606. PubMed ID: 30094492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
    Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
    Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory.
    Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
    J Am Soc Cytopathol; 2015; 4(2):84-89. PubMed ID: 31051714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study.
    Yu L; Chen X; Liu X; Fei L; Ma H; Tian T; Wang L; Chen S
    Front Oncol; 2022; 12():915418. PubMed ID: 35747800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
    Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
    Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triaging Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion With p16/Ki67 Dual Stain.
    Šekoranja D; Repše Fokter A
    J Low Genit Tract Dis; 2017 Apr; 21(2):108-111. PubMed ID: 28244884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
    Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
    PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Years of Cytology and HPV Co-Testing in Germany: Initial Experience.
    Xhaja A; Ahr A; Zeiser I; Ikenberg H
    Geburtshilfe Frauenheilkd; 2022 Dec; 82(12):1378-1386. PubMed ID: 36467972
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of p16/Ki-67 and p16/mcm2 on the detection of cervical intraepithelial neoplasia: a prospective study from China.
    Liao GD; Kang LN; Li J; Zeng X; Chen W; Xi MR
    Int J Clin Exp Pathol; 2018; 11(8):4101-4108. PubMed ID: 31949801
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.